- CA$27.00m
- CA$34.09m
- CA$25.46m
- 53
- 32
- 48
- 41
Annual income statement for Avicanna, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.57 | 3.27 | 4.05 | 16.8 | 25.5 |
| Cost of Revenue | |||||
| Gross Profit | 1.06 | 1.37 | 1.87 | 7.62 | 13.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 33.3 | 18.8 | 17.1 | 25.2 | 30.1 |
| Operating Profit | -31.7 | -15.6 | -13.1 | -8.38 | -4.68 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -35 | -16.8 | -14.7 | -8.74 | -3.62 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -32.9 | -16.8 | -14.7 | -8.74 | -3.62 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -32.9 | -16.8 | -14.7 | -8.74 | -3.62 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -32.9 | -16.8 | -14.7 | -8.74 | -3.62 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.784 | -0.365 | -0.192 | -0.092 | -0.032 |